Szerző szerinti böngészés "Ferrari, Filippo Alberto"

Megjelenítve 1 - 1 (Összesen 1)
  • Nincs kép
    TételSzabadon hozzáférhető
    Effects of transdermal versus oral hormone replacement therapy in postmenopause: a systematic review
    Goldštajn, Marina Šprem; Mikuš, Mislav; Ferrari, Filippo Alberto; Bosco, Mariachiara; Uccella, Stefano; Noventa, Marco; Török, Peter; Terzic, Sanja; Laganà, Antonio Simone; Garzon, Simone; Török Péter (1975-) (szülész-nőgyógyász); Szülészeti és Nőgyógyászati Intézet -- 40; ÁOK; Debreceni Egyetem
    Purpose To summarize available evidence comparing the transdermal and the oral administration routes of hormone replacement therapy (HRT) in postmenopausal women. Methods We performed a systematic review of the literature on multiple databases between January 1990 and December 2021. We included randomized controlled trials and observational studies comparing the transdermal and oral administration routes of estrogens for HRT in postmenopausal women regarding at least one of the outcomes of interest: cardiovascular risk, venous thromboembolism (VTE), lipid metabolism, carbohydrate metabolism, bone mineral density (BMD), and risk of pre-malignant and malignant endometrial lesions, or breast cancer. Results The systematic literature search identified a total of 1369 manuscripts, of which 51 were included. Most studies were observational and of good quality, whereas the majority of randomized controlled trials presented a high or medium risk of bias. Oral and transdermal administration routes are similar regarding BMD, glucose metabolism, and lipid profile improvements, as well as do not appear different regarding breast cancer, endometrial disease, and cardiovascular risk. Identified literature provides clear evidence only for the VTE risk, which is higher with the oral administration route. Conclusions Available evidence comparing the transdermal and oral administration routes for HRT is limited and of low quality, recommending further investigations. VTE risk can be considered the clearest and strongest clinical difference between the two administration routes, supporting the transdermal HRT as safer than the oral administration route.